<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Criteria, scoring systems, and treatment algorithms for <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) have been updated repeatedly in recent years </plain></SENT>
<SENT sid="1" pm="."><plain>This apparently results from increased awareness and early recognition of the disease, an increasing number of new diagnostic and prognostic markers and tools, and new therapeutic options that may change the course and thus prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To address these challenges and to create useful new diagnostic and prognostic parameters and scores, the German-Austrian Working Group for Studying Prognostic Factors in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was established in 2003 and later was extended to centers in Switzerland (D-A-CH group) </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, the group cooperates with the European LeukemiaNet, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> Foundation, and other national and international working groups in order to improve diagnosis and prognostication </plain></SENT>
<SENT sid="4" pm="."><plain>The current article represents a meeting report from the latest workshop organized by the group in Vienna in October 2008 </plain></SENT>
</text></document>